Discover 604 paid clinical trials in Lincoln, Nebraska. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Lincoln offers a wide variety of trials focused on numerous chronic conditions like diabetes, mental health disorders, and cardiovascular diseases. Participants, including healthy volunteers seeking paid research opportunities or those with a particular health condition, can explore new treatment options while contributing to the development of groundbreaking therapies.
Filter
2
Filter results
Results: 604
New
A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
for
Influenza, Human
Location: Elkhorn NE, Omaha NE, Grand Island NE, Norfolk NE,
Sponsor: GlaxoSmithKline
Sex: All
Age: 65+
Code: NCT07805707
Phase3, Recruiting
A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age
for
Chickenpox
Location: Lincoln NE, Mankato MN, Chicago IL, Dallas TX,
Sponsor: GlaxoSmithKline
Sex: All
Age: 1
Code: NCT06693895
Phase3, Recruiting
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
for
Chickenpox
Location: Lincoln NE, Topeka KS, Jefferson City MO, Moline IL,
Sponsor: GlaxoSmithKline
Sex: All
Age: 1
Code: NCT06740630
Phase3, Recruiting
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
for
Neoplasms, Head and Neck
Location: Omaha NE, Iowa City IA, Tulsa OK, St Louis MO,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT06256588
Phase3, Recruiting
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
for
Colonic Neoplasms, Neoplasms, Colon
Location: Omaha NE, Grand Island NE, Westwood KS, Sioux Falls SD,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT05855200
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer
for
Breast Cancer
Location: Omaha NE, Rochester MN, Houston TX, San Antonio TX,
Sponsor: Biotheryx, Inc.
Sex: All
Age: 18+
Code: NCT06515470
Phase1, Recruiting
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
for
Prostate Cancer
Location: Omaha NE, Rochester MN, St Louis MO, Aurora CO,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18 - 70+
Code: NCT05803941
Recruiting
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
for
Prostate Cancer,
Location: Omaha NE, Atlanta GA, Miami FL
Sponsor: Blue Earth Therapeutics Ltd
Sex: Male
Age: 18+
Code: NCT05413850
Phase1, Phase2, Recruiting
Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer (CRPC)
for
PSMA PET-Positive Castration-Resistant Prostate Cancer
Location: Omaha NE, St Louis MO, Cleveland OH, Durham NC,
Sponsor: Convergent Therapeutics
Sex: Male
Age: 18+
Code: NCT06549465
Phase2, Recruiting
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
for
Cervical Cancer, Breast Cancer, Colon Cancer, NSCLC,
Location: Omaha NE, Lexington KY, Glen Burnie MD
Sponsor: Orano Med Theranostics, SAS
Sex: All
Age: 18+
Code: NCT05283330
Phase1, Recruiting
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
for
Renal Cell Carcinoma (RCC),
Location: Omaha NE, Rochester MN, Littleton CO, Chicago IL,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT05176483
Phase1, Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
for
Colorectal Neoplasms
Location: Omaha NE, Waukee IA, Wichita KS, Iowa City IA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06662786
Phase3, Recruiting
Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)
for
Small Cell Lung Cancer
Location: Omaha NE, Grand Rapids MI, Orlando FL
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07778316
Phase3, Recruiting
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
for
Cancer Harboring BRAF Alterations, HGG, LGG, Solid Tumors
Location: Omaha NE, Saint Joseph MO, Duluth MN, Dallas TX,
Sponsor: Fore Biotherapeutics
Sex: All
Age: 8+
Code: NCT05503797
Phase2, Recruiting
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7